Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore ways to use credit card points effectively with smart strategies. Maximize your rewards and get more from your spending.
23,022 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
A federal jury awarded $3 million to a woman in the first-ever social media addiction trial against Meta and Google, ...
Blossom Health has secured $20 million in seed and Series A funding to roll out an AI copilot for psychiatry across t...
Berkshire Hathaway finished the year with a cash pile near 375 billion, underscoring a cautious stance that lagged br...
Firms are tightening AI requirements across industries, pushing workers to upskill quickly. This article breaks down ...
The mood around U.S. housing is shifting. Prices, rents, and mortgage costs are moving in ways that could change how ...
Palantir just beat earnings, yet its stock fell in after-hours trading as traders priced in slower growth and macro h...
A single month brought a sharp rally for Sirius XM as two big catalysts emerged: a new YouTube partnership expanding ...
As wage growth stalls for some workers, investors pursue dividend income. This piece examines how a $500,000 dividend...
Tron’s TRX surged in 2026, yet fresh on-chain data points to a potential correction risk as price outpaces network ac...